Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $15.11 $17.90 Friday, 10th May 2024 ACAD stock ended at $15.25. This is 0.263% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 2.78% from a day low at $15.11 to a day high of $15.53.
90 days $15.11 $26.78
52 weeks $15.11 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Aug 11, 2016 $31.87 $31.87 $31.87 $31.87 1 974 400
Aug 10, 2016 $31.08 $31.08 $31.08 $31.08 6 760 000
Aug 09, 2016 $33.34 $33.34 $33.34 $33.34 4 384 400
Aug 08, 2016 $35.23 $35.23 $35.23 $35.23 2 221 200
Aug 05, 2016 $36.49 $36.49 $36.49 $36.49 2 851 400
Aug 04, 2016 $36.48 $36.48 $36.48 $36.48 1 969 900
Aug 03, 2016 $37.17 $37.17 $37.17 $37.17 1 402 400
Aug 02, 2016 $36.59 $36.59 $36.59 $36.59 1 689 500
Aug 01, 2016 $37.23 $37.23 $37.23 $37.23 1 500 100
Jul 29, 2016 $37.04 $37.04 $37.04 $37.04 1 210 800
Jul 28, 2016 $36.74 $36.74 $36.74 $36.74 1 345 300
Jul 27, 2016 $37.44 $37.44 $37.44 $37.44 1 417 500
Jul 26, 2016 $36.79 $36.79 $36.79 $36.79 1 380 400
Jul 25, 2016 $36.31 $36.31 $36.31 $36.31 1 493 400
Jul 22, 2016 $36.55 $36.55 $36.55 $36.55 1 522 500
Jul 21, 2016 $36.06 $36.06 $36.06 $36.06 3 170 400
Jul 20, 2016 $34.65 $34.65 $34.65 $34.65 3 422 300
Jul 19, 2016 $32.74 $32.74 $32.74 $32.74 908 400
Jul 18, 2016 $33.25 $33.25 $33.25 $33.25 1 321 900
Jul 15, 2016 $33.00 $33.00 $33.00 $33.00 1 069 400
Jul 14, 2016 $32.62 $32.62 $32.62 $32.62 1 241 200
Jul 13, 2016 $32.92 $32.92 $32.92 $32.92 1 632 600
Jul 12, 2016 $34.68 $34.68 $34.68 $34.68 1 302 000
Jul 11, 2016 $33.92 $33.92 $33.92 $33.92 1 395 100
Jul 08, 2016 $34.62 $34.62 $34.62 $34.62 1 825 000
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT